Company page

Co-diagnostics, Inc.

Co-Diagnostics, Inc. is a public company traded under the ticker CODX in the American market. With a market capitalization of approximately $12.4 million, the company focuses on developing and manufacturing molecular diagnostic solutions. Their innovative technologies aim to enhance disease detection and management.